Effect of Melothria maderaspatana leaf-tea consumption on blood pressure, lipid profile, anthropometry, fibrinogen, bilirubin, and albumin levels in patients with hypertension

Journal of Alternative and Complementary Medicine

Volumn 13, Issue 3, 2007, Pages 349-354

  Raja, Boobalan ^a   Kaviarasan, Kuppusamy ^a   Arjunan, Mangalam Muthu ^b   Pugalendi, Kodukkur Viswanathan ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b Government Kamaraj Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELOTHRIA MADERASPATANA EXTRACT; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PHOSPHOLIPID BLOOD LEVEL; PLANT LEAF; PRIORITY JOURNAL; PULSE RATE; SYSTOLIC BLOOD PRESSURE; TEA; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ANTIHYPERTENSIVE AGENTS; BILIRUBIN; BLOOD PRESSURE; CHOLESTEROL; FEMALE; FIBRINOGEN; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; OBESITY; PHYTOTHERAPY; SERUM ALBUMIN; TEA; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 34247603924     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2006.5373     Document Type: Article

References (45)

1. Anonymous. Executive summary of the third report of the national cholesterol education program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-2497.
2. Benderly M, Graff E, Reicher-Reiss H, et al. Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction prevention (BIP) Study Group. Arterioscler Throm Vasc Biol 1996;16:351-356.
3. Breimer LH, Ganotakis ES, Mikhailidis DP. Fibrinogen as a cardiovascular risk factor. Rev Port Cardiol 1997;16:245-250.
4. Hopkins PN, Wu LL, Hunt SC, et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Throm Vasc Biol 1996;16:250-255.
5. Mikhailidis DP, Ganotakis ES. Plasma albumin and platelet function: Relevance to atherogenesis and thrombosis. Platelets 1996;7;125-137.
6. Nadkarani KN. Indian Materia Medica. Bombay: Prakashan Pvt Ltd., 1971:820.
7. Publication and Information Directorate. The Wealth of India. New Delhi: C.S.I.R., 1962:336.
8. Kirtikar KR, Basu BD. Indian Medicinal Plants, 2nd ed., vol. III. New Delhi, India: International Book Distributors, 1975:1161.
9. Attygalle J. Sinhalese Materia Medica, 2nd ed. Colombo, Sri Lanka: M.D. Gunasena & Co. Ltd., 1952:91.
10. Jayaweera DMA Medicinal Plants Used in Ceylon, Vols 1-5. Colombo, Sri Lanka: National Science Council, 1982:47, 153.
11. Marundugalin UK. Treatment for High Blood Pressure: Tamil Nadu, India: SKM Udal Matrum Mana Nala Arakkattalai, 173.
12. Jayatilaka KAPW, Thabrew MI, Perera DJB. Effect of Melothria maderaspatana on carbon tetrachloride-induced changes in rat hepatic microsomal drug-metabolising enzyme activity. J Ethno Pharm 1990;30:97-105.
13. Jayatilaka KAPW, Thabrew MI, Pathirana C, et al. An evaluation of the potency of Osbeckia octandra and Melothria maderaspatana as anti hepatotoxic agents. Plan Med 1989;55:137-139.
14. Thabrew MI, de Silva KTD, Labadie RP, et al. Immunomodulatory activity of three Sri-Lankan medicinal plants used in hepatic disorders. J Ethno Pharm 1991;33:63-66.
15. Thabrew MI, Jayatilaka KAPW, Perera DJB. Evaluation of the efficacy of Melothria maderaspatana in the alleviation of carbon tetrachloride- induced liver dysfunction. J Ethno Pharm 1988;23:305-312.
16. Thabrew MI, Gove CD, Robin D. Protection against galactosamine and tert-butyl hydroperoxide induced hepatocyte damage by Melothria maderaspatana leaf extract. Phyto Res 1995;9:513-517.
17. Ramakrishanamacharya CH, Krishnaswamy MR, Rao RB. Anti-inflammatory efficacy of Melothria maderaspatana in active rheumatoid arthritis. Clin Rheumatol 1996;15:214-215.
18. Raja B, Kaviarasan K, Arjunan MM, et al. Melothria maderaspatana leaf leaf-extract for treating hypertension: Chemistry and effects on biomarkers. J Altern Complement Ther 2005;11:264-268.
19. Siedel J, Hagele EO, Ziegenhorn J, et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;20:1075.
20. Friedwald WT, Levy RI, Fredricson DS. Estimation of concentration of low-density lipoprotein in plasma, without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. McGowan MW, Artiss JD, Zak BA. Peroxidase coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538.
22. Falholt K, Falholt W, Lund B. An easy colorimetric method for routine determination of free fatty acid in plasma. Clin Chim Acta 1968;46:105-11.
23. Stewart JCM. Colorimetric determination of phospholipids with ammonium ferrocynate. Ann Biochem 1980;104:10-14.
24. Clauss A. Rapid physiological coagulation method in determination of fibrinogen [in German]. Acta Haematol 1957;17:237-246.
25. Corcoran RM, Durnan SM. Albumin determination by a modified bromocresol green method. Clin Chem 1977;23:765.
26. Malloy AF, Evelyn KA. The determination of bilirubin with the photometric colorimeter. J Biol Chem 1937;119:481-490.
27. Mbwambo ZH, Luyengi L, Kinghorn AD. Phytochemicals: A glimpse into their structural and biological variation. Int J Pharm 1996;34:335-343.
28. Sinha BN, Sasmal D, Basu SP. Pharmacological studies on Melothria maderaspatana. Fitoter 1997;68:75-78.
29. Sinha BN, Thanigavelan J, Basu SP, et al. Studies on Melothria maderaspatana (Linn). Cogn And Sci Life 1996;15:238-240.
30. Stevens J, Cai J, Pamuk E. The effect of age on the association between body mass index and mortality. N Engl J Med 1998;338:1-7.
31. Law M. Plant sterol and stanol margarines and health. Br Med J 2000;320:861-864.
32. Cater NB. Plant stanol ester: Review of cholesterol-lowering efficacy and implications for coronary heart disease risk reduction. Prev Card 2000;3:121-130.
33. Lichtenstein AH, Deckelbaum RJ. Stanol/Sterol ester-containing foods and blood cholesterol levels: A statement for healthcare professionals from the nutrition committee of the council of nutrition, physical activity and metabolism of the American Heart Association. Circulation 2001;103:1177.
34. Sailaja YR, Baskar R, Srinivas Rao CS, et al. Membrane lipids and protein-bound carbohydrates status during the maturation of reticulocytes to erythrocytes in type 2 diabetics. Clin Chim Acta 2004;341:185-192.
35. Kumari SS, Menon VP. Changes in concentration of lipid peroxides and activities of super oxide dismutase and catalase in isoproterenol induced myocardial infarction in rats. Indian J Exp Biol 1987;25:419-423.
36. Letcher RL, Chien S, Pickering TG, et al. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: Role of fibrinogen concentration. Am J Med 1981;70:1195-1202.
37. Lee AJ, Lowe GDO, Woodward M, et al. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease and family history. Br Heart J 1993;69:338-342.
38. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987;258:1183-1186.
39. Tsagadopoulos D, Antonakoudis H, Makris T, et al. Effect of antihypertensive treatment on lipids and fibrinogen: Greek multicentre study of cilazapril. Cardiology 1996;87:524-528.
40. Haenni A, Litheell H. Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension. Metab Clin Exp 1996;45:1221-1229.
41. Doolittle RF. Fibrinogen and fibrin. In: Bloom AL, Forbes CB, Thomas DP, et al., eds. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone, 1994;491-513.
42. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46:1723-1727.
43. Yamaguchi T, Terakado M, Horio F, et al. Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. Biochem Biophys Res Commun 1996;223:129-135.
44. Parik T, Allikmets K, Teesalu R, et al. Evidence for oxidative stress in essential hypertension: Perspective for antioxidant therapy. J Cardiovasc Risk 1996;3:49-54.
45. Halliwell B. Albumin-an important extracellular antioxidant. Biochem Pharm 1988;37:569-571.